Advertisement for orthosearch.org.uk
Results 1 - 20 of 45
Results per page:
Bone & Joint Research
Vol. 10, Issue 10 | Pages 690 - 692
1 Oct 2021
Hoellwarth JS Tetsworth K Akhtar MA Al Muderis M


The Bone & Joint Journal
Vol. 95-B, Issue 4 | Pages 433 - 433
1 Apr 2013
Villar RN


The Journal of Bone & Joint Surgery British Volume
Vol. 94-B, Issue 12 | Pages 1586 - 1588
1 Dec 2012
Horan FT


The Bone & Joint Journal
Vol. 106-B, Issue 7 | Pages 642 - 645
1 Jul 2024
Harris IA Sidhu VS MacDessi SJ Solomon M Haddad FS


The Bone & Joint Journal
Vol. 105-B, Issue 4 | Pages 341 - 342
15 Mar 2023
Haddad FS


The Bone & Joint Journal
Vol. 105-B, Issue 7 | Pages 717 - 718
1 Jul 2023
Haddad FS


Bone & Joint 360
Vol. 12, Issue 4 | Pages 3 - 4
1 Aug 2023
Ollivere B


The Bone & Joint Journal
Vol. 105-B, Issue 2 | Pages 99 - 100
1 Feb 2023
Birch NC Tsirikos AI


Bone & Joint Research
Vol. 12, Issue 5 | Pages 306 - 308
1 May 2023
Sharrock M Board T

Cite this article: Bone Joint Res 2023;12(5):306–308.


The Bone & Joint Journal
Vol. 105-B, Issue 6 | Pages 587 - 589
1 Jun 2023
Kunze KN Jang SJ Fullerton MA Vigdorchik JM Haddad FS

The OpenAI chatbot ChatGPT is an artificial intelligence (AI) application that uses state-of-the-art language processing AI. It can perform a vast number of tasks, from writing poetry and explaining complex quantum mechanics, to translating language and writing research articles with a human-like understanding and legitimacy. Since its initial release to the public in November 2022, ChatGPT has garnered considerable attention due to its ability to mimic the patterns of human language, and it has attracted billion-dollar investments from Microsoft and PricewaterhouseCoopers. The scope of ChatGPT and other large language models appears infinite, but there are several important limitations. This editorial provides an introduction to the basic functionality of ChatGPT and other large language models, their current applications and limitations, and the associated implications for clinical practice and research.

Cite this article: Bone Joint J 2023;105-B(6):587–589.


Bone & Joint Research
Vol. 12, Issue 1 | Pages 5 - 8
1 Jan 2023
Im G

Cite this article: Bone Joint Res 2023;12(1):5–8.


Bone & Joint 360
Vol. 11, Issue 4 | Pages 3 - 3
1 Aug 2022
Ollivere B


Bone & Joint 360
Vol. 10, Issue 4 | Pages 3 - 4
1 Aug 2021
Ollivere B


Bone & Joint Research
Vol. 10, Issue 2 | Pages 134 - 136
1 Feb 2021
Im G

The high prevalence of osteoarthritis (OA), as well as the current lack of disease-modifying drugs for OA, has provided a rationale for regenerative medicine as a possible treatment modality for OA treatment. In this editorial, the current status of regenerative medicine in OA including stem cells, exosomes, and genes is summarized along with the author’s perspectives. Despite a tremendous interest, so far there is very little evidence proving the efficacy of this modality for clinical application. As symptomatic relief is not sufficient to justify the high cost associated with regenerative medicine, definitive structural improvement that would last for years or decades and obviate or delay the need for joint arthroplasty is essential for regenerative medicine to retain a place among OA treatment methods.

Cite this article: Bone Joint Res 2021;10(2):134–136.


Bone & Joint 360
Vol. 9, Issue 6 | Pages 3 - 4
1 Dec 2020
Ollivere B


The Bone & Joint Journal
Vol. 102-B, Issue 11 | Pages 1429 - 1430
1 Nov 2020
Haddad FS


Bone & Joint 360
Vol. 9, Issue 3 | Pages 3 - 3
1 Jun 2020
Ollivere B


The Bone & Joint Journal
Vol. 101-B, Issue 3 | Pages 236 - 237
1 Mar 2019
Perry DC Paton RW


The Bone & Joint Journal
Vol. 101-B, Issue 6 | Pages 625 - 626
1 Jun 2019
Price AJ Haddad FS Beard DJ


Bone & Joint Research
Vol. 7, Issue 12 | Pages 636 - 638
1 Dec 2018
Roussot MA Haddad FS